Financials

  • Market Capitalization 2.58 B
  • Employee 177
  • Founded 2006
  • CEO N/A
  • Website www.immunome.com
  • Headquarter Delaware, United States
  • FIGI BBG00BR93ZG8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.84
Price to sales ratio
100.55

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1736
IRON
Disc Medicine, Inc. - Common Stock
75.98 USD-0.80%-2.71%+10.02%+31.02%2.90 B USD
1822
QURE
uniQure N.V. - Ordinary Shares
41.10 USD-3.59%-1.93%+48.11%+181.51%2.59 B USD
1829
KOD
Kodiak Sciences Inc - Common Stock
41.10 USD-0.51%+9.34%+17.80%+675.47%2.57 B USD
1836
TARS
Tarsus Pharmaceuticals, Inc. - Common Stock
59.31 USD+2.01%-13.26%-4.46%-10.22%2.55 B USD

Frequently asked questions about Immunome, Inc. - Common Stock

What is the Immunome, Inc. - Common Stock stock price today?

The current price of Immunome, Inc. - Common Stock (IMNM) is 22.8. Over the past 24 hours, the stock has changed by -2.36%. Follow the IMNM chart for real-time price dynamics.

What is the stock ticker of Immunome, Inc. - Common Stock?

Immunome, Inc. - Common Stock trades under the ticker IMNM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Immunome, Inc. - Common Stock stock going up?

IMNM has changed by -5.00% over the last week, +22.38% over the last month, and +166.36% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Immunome, Inc. - Common Stock net income for the last quarter?

Immunome, Inc. - Common Stock reported net income of -53.84 M for the last quarter. The previous quarter showed -69.9 M, which means net income changed by +22.98%.

How many employees does Immunome, Inc. - Common Stock have?

As of the latest available data, Immunome, Inc. - Common Stock has 177 employees. Workforce size can provide additional context about the company's scale and operations.

What is Immunome, Inc. - Common Stock EBITDA?

Immunome, Inc. - Common Stock EBITDA is -53.24 M, and its EBITDA margin is -969.34%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Immunome, Inc. - Common Stock stock?

You can buy Immunome, Inc. - Common Stock (IMNM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Immunome, Inc. - Common Stock stock?

Investing in Immunome, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMNM chart and related analysis on metatrader.com as part of your research.

News